Deletion of p120-Catenin Results in a Tumor Microenvironment with Inflammation and Cancer that Establishes It as a Tumor Suppressor Gene-Reference-Cited by-同舟云学术

Deletion of p120-Catenin Results in a Tumor Microenvironment with Inflammation and Cancer that Establishes It as a Tumor Suppressor Gene

Published:2011-04 Issue:4 Volume:19 Page:470-483
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Stairs Douglas B.,Bayne Lauren J.,Rhoades Ben,Vega Maria E.,Waldron Todd J.,Kalabis Jiri,Klein-Szanto Andres,Lee Ju-Seog,Katz Jonathan P.,Diehl J. Alan,Reynolds Albert B.,Vonderheide Robert H.,Rustgi Anil K.

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference49 articles.

1. Inhibition of RhoA by p120 catenin;Anastasiadis;Nat. Cell Biol.,2000

2. Epidermal growth factor receptor mediates increased cell proliferation, migration, and aggregation in esophageal keratinocytes in vitro and in vivo;Andl;J. Biol. Chem.,2003

3. FcRgamma activation regulates inflammation-associated squamous carcinogenesis;Andreu;Cancer Cell,2010

4. Targeted p120-catenin ablation disrupts dental enamel development;Bartlett;PLoS ONE,2010

5. SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas;Bass;Nat. Genet.,2009

Cited by 171 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Functional analysis of ESRP1/2 gene variants and CTNND1 isoforms in orofacial cleft pathogenesis;Communications Biology;2024-08-23

2. Functional analysis ofESRP1/2gene variants andCTNND1isoforms in orofacial cleft pathogenesis;2024-07-02

3. Cadherin‐6 is a novel mediator for the migration of mesenchymal stem cells to glioblastoma cells in response to stromal cell‐derived factor‐1;FEBS Open Bio;2024-05-08

4. Microenvironmental regulation in tumor progression: Interactions between cancer-associated fibroblasts and immune cells;Biomedicine & Pharmacotherapy;2023-11

5. Preclinical tumor mouse models for studying esophageal cancer;Critical Reviews in Oncology/Hematology;2023-09